Valproic acid and ivermectin increase GABA levels to improve the viability of skin flaps in rats
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240199Keywords:
Extended random skin flap, Flap necrosis, GABA, Ivermectin, Valproic acidAbstract
Background: Gamma-aminobutyric acid (GABA) is a nonproteinogenic amino acid known as the main inhibitory neurotransmitter in the central nervous system. Ivermectin (IVM) and valproic acid (VA), both increase GABA levels. The purpose of this study was to determine the effect of VA and IVM on the viability of extended random-pattern skin flaps in Wistar rats and their GABA-dependent mechanisms.
Methods: This experimental study used 32 Wistar rats that underwent surgery to have caudally based extended random-pattern skin flaps divided into four distinct groups. In the first group, 0.05 mg/kg IVM was administered via intraperitoneal (i.p.) injection 30 minutes (min) prior to elevating the flap. The second group was administered 100 mg/kg VA by i.p. injection 60 min prior to elevating the flap. The third group was administered VA 100 mg/kg followed by IVM 0.05 mg/kg injected (i.p.) 60 min and 30 min prior to flap elevation, respectively. The fourth group was used as a control. After 7 days, the percentage of flap viability was measured, and tissue sampling was performed to examine GABA levels.
Results: It was found that the highest viability rate was in the group administered VA combined with IVM (93.98%) compared to all other groups (p<0.001). The highest GABA levels in the tissue were observed in the group administered VA combined with IVM (284.91 nmol/l) compared to all other groups (p<0.001).
Conclusions: IVM in combination with VA improves the viability of extended random-pattern skin flaps by increasing GABA levels.
Metrics
References
Basu G, Downey H, Guo S, Israel A, Asmar A, Hargrave B, et al. Pro-opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through a melanocortin-1 receptor-independent pathway. J Gene Med. 2014;14(1):44-53.
Krauss S, Rothenberger J, Mayer J, Sogorski A, Held M, Wahler T, et al. Tissue conditioning- strategies to improve perfusion and reduce ischemia- reperfusion injury. Plast Aesthetic Res. 2018;5(9):39.
Bozkurt M, Sezgic M, Karakol P, Uslu C, Balikci T. The effect of antioxidants on ischemia-reperfusion injury in flap surgery. In: Shalaby E, ed. Antioxidants. Vol. 5. IntechOpen; 2019.
Chen C, Zhou X, He J, Xie Z, Xia S, Lu G. The roles of GABA in ischemia-reperfusion injury in the central nervous system and peripheral organs. Oxid Med Cell Longev. 2019;2019.
Tabary M, Aryannejad A, Noroozi N, Tavangar SM, Mohammad Jafari R, Araghi F, et al. Ivermectin increases random-pattern skin flap survival in rats: the novel role of GABAergic system. J Surg Res. 2021;259:431-41.
Ala M, Mohammad Jafari R, Nematian H, Ganjedanesh MR, Dehpour AR. Sodium valproate improves skin flap survival via gamma-aminobutyric acid and histone deacetylase inhibitory system. J Surg Res. 2020;246:519-26.
Steiner SA, Schweizer R, Klein H, Waldner M, Giovanoli P, Plock JA. Abdominal, perineal, and genital soft tissue reconstruction with pedicled anterolateral thigh perforator flaps. Eur J Plast Surg. 2021;44(5):669-77.
Taylor P, Campbell WC. New Zealand Veterinary Journal. 2011;(November 2014):37–41.
Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA. 2010;107(6):2580-5.
Chen LJ, Sun BH, Cao Y, Yao HD, Qu JP, Liu C, et al. The effects of avermectin on amino acid neurotransmitters and their receptors in the pigeon brain. Pestic Biochem Physiol. 2014;110(1):13-9.
Husna M, Kurniawan SN. biomolecular mechanism of anti epileptic drugs. Malang Neurol J. 2018;4(1):38-45.
Brunton LL. Goodman and Gillman’s the Parmacological basis of Therapeutics 13th edn. New York: McGraw-Hill; 2018:319.